BioCentury
ARTICLE | Clinical News

Biovail Corp. International regulatory update

November 2, 1998 8:00 AM UTC

BVF filed an ANDA with the FDA for its generic version of Dilacor XR diltiazem to treat cardiovascular disease. ...